Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
7.76
-0.48 (-5.83%)
Jan 30, 2026, 4:00 PM EST - Market closed
Addex Therapeutics Employees
Addex Therapeutics had 2 employees as of December 31, 2024. The number of employees decreased by 21 or -91.30% compared to the previous year.
Employees
2
Change (1Y)
-21
Growth (1Y)
-91.30%
Revenue / Employee
$99,412
Profits / Employee
-$3,823,143
Market Cap
7.53M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 2 | -21 | -91.30% |
| Dec 31, 2023 | 23 | -1 | -4.17% |
| Dec 31, 2022 | 24 | -2 | -7.69% |
| Dec 31, 2021 | 26 | -1 | -3.70% |
| Dec 31, 2020 | 27 | 8 | 42.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Aptevo Therapeutics | 37 |
| Calidi Biotherapeutics | 28 |
| VivoSim Labs | 13 |
| XTL Biopharmaceuticals | 10 |
| MetaVia | 9 |
| Immuron | 7 |
| Alzamend Neuro | 7 |
| Mustang Bio | 6 |
ADXN News
- 26 days ago - Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia - GlobeNewsWire
- 7 weeks ago - Addex Amends its at the Market Offering Agreement With H.C. Wainwright & Co. - GlobeNewsWire
- 2 months ago - Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Addex Therapeutics Reports 2025 Third Quarter Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Addex Therapeutics to Report 2025 Third Quarter Financial Results And Host Conference Call on December 4, 2025 - GlobeNewsWire
- 4 months ago - Addex Therapeutics Ltd (ADXN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Addex Therapeutics Reports 2025 Half Year and Second Quarter Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - Addex Therapeutics to Report 2025 Half-year and Second Quarter Financial Results on September 30, 2025 and Host Conference Call on October 1, 2025 - GlobeNewsWire